Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies
OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
[PDF][PDF] Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies
OJ Storebø, N Pedersen, E Ramstad… - status and date: New …, 2018 - researchgate.net
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies
OJ Storebø, N Pedersen, E Ramstad… - The Cochrane …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of harmful effects in non-randomised studies
OJ Storebø, N Pedersen… - Cochrane …, 2016 - findresearchersdu.elsevierpure.com
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and
adolescents: assessment of harmful effects in non-randomised studies — Syddansk …
adolescents: assessment of harmful effects in non-randomised studies — Syddansk …
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of harmful effects in non-randomised studies
OJ Storebo, N Pedersen, E Ramstad, HB Krogh… - 2016 - um.edu.mt
Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and
treated childhood psychiatric disorders (Scahill 2000). The estimated prevalence in children …
treated childhood psychiatric disorders (Scahill 2000). The estimated prevalence in children …
[HTML][HTML] Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies
OJ Storebø, N Pedersen, E Ramstad… - The Cochrane …, 2018 - ncbi.nlm.nih.gov
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
[HTML][HTML] Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies
OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - research.regionh.dk
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies
OJ Storebø, N Pedersen… - Cochrane …, 2018 - portal.findresearcher.sdu.dk
Background: Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies
OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 1996 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of harmful effects in non-randomised studies
OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database of …, 2016 - vbn.aau.dk
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents:
assessment of harmful effects in non-randomised studies — Aalborg University's Research …
assessment of harmful effects in non-randomised studies — Aalborg University's Research …